Business Context and Reporting Period
Company: Armstrong World Industries, Inc.
Filing Type: Form 8-K (Current Report)
Date: September 17, 2018
Event: Regulation FD Disclosure regarding a milestone payment received from Knauf International GmbH under a Share Purchase Agreement dated November 17, 2017.
Key Financial Metrics
This filing reports a specific transaction payment rather than periodic financial performance metrics (e.g., revenue, profit, or margins).
- Payment Received: $80 million paid by Knauf International GmbH on September 17, 2018.
- Previous Payment: $250 million paid by Knauf on August 1, 2018.
- Total Consideration: $330 million in cash (subject to adjustments) for the sale of subsidiaries.
- Assets Sold: Business operations in Europe, the Middle East, Africa (including Russia), and the Pacific Rim, including a 50% interest in Worthington Armstrong Venture (WAVE).
Material Changes
The filing discloses the receipt of the second tranche of the purchase price for the divestiture of the Company's international operations. The $80 million payment, combined with the prior $250 million payment, equals the full $330 million consideration. These funds are credited against the total consideration due at closing.
Guidance, Outlook, and Risks
- Closing Expectation: The Company expects the transaction to close prior to December 31, 2018.
- Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ from expectations due to economic, business, competitive, technological, strategic, or regulatory factors.
- Risks: There is a risk that anticipated benefits from the sale may not be fully realized or may take longer to realize than expected.
Investor Verification Checklist
- Verify the final closing date of the transaction to confirm it occurs before December 31, 2018.
- Monitor for any purchase price adjustments that could alter the final $330 million consideration.
- Review subsequent filings for the impact of this divestiture on the Company's consolidated revenue and geographic exposure.
- Confirm the treatment of the $330 million proceeds in the Company's cash flow statement upon closing.